Holen Sie sich die Stockscreener-App
3.95
8.22%
0.30
Handel nachbörslich:
3.88
-0.07
-1.77%
Schlusskurs vom Vortag:
$3.65
Offen:
$3.79
24-Stunden-Volumen:
196.29K
Relative Volume:
2.31
Marktkapitalisierung:
$149.46M
Einnahmen:
$15.33M
Nettoeinkommen (Verlust:
$-40.19M
KGV:
-2.2543
EPS:
-1.7522
Netto-Cashflow:
-
1W Leistung:
+0.00%
1M Leistung:
-19.22%
6M Leistung:
-28.57%
1J Leistung:
-31.30%
1-Tages-Spanne:
$3.45
$4.00
1-Wochen-Bereich:
$3.42
$4.05
52-Wochen-Spanne:
$3.42
$6.04
Trisalus Life Sciences Inc Stock (TLSI) Company Profile
Firmenname
Trisalus Life Sciences Inc
Sektor
Branche
Telefon
415 336 8917
Adresse
6272 WEST 91ST AVENUE, WESTMINSTER
Vergleichen Sie TLSI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TLSI
Trisalus Life Sciences Inc
|
3.95 | 138.61M | 15.33M | -40.19M | 0 | -1.7522 |
|
ABT
Abbott Laboratories
|
129.40 | 228.03B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.50 | 152.09B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
378.95 | 143.98B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.91 | 117.98B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.68 | 45.17B | 5.69B | 1.41B | 577.90M | 6.95 |
Trisalus Life Sciences Inc Stock (TLSI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-13 | Eingeleitet | Lake Street | Buy |
| 2024-12-17 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-11-11 | Eingeleitet | ROTH MKM | Buy |
| 2024-10-25 | Eingeleitet | Northland Capital | Outperform |
| 2024-09-16 | Eingeleitet | Oppenheimer | Outperform |
| 2024-05-30 | Eingeleitet | Canaccord Genuity | Buy |
Alle ansehen
Trisalus Life Sciences Inc Aktie (TLSI) Neueste Nachrichten
TriSalus Life Sciences Reports Strong Growth Amid Challenges - TipRanks
Understanding TriSalus Life Sciences Inc. Equity Warrant’s price movement2025 Key Highlights & Weekly Setup with ROI Potential - Newser
What moving averages say about TriSalus Life Sciences Inc.2025 Earnings Impact & High Conviction Trade Alerts - Newser
What technical models suggest about TriSalus Life Sciences Inc.’s comebackEarnings Performance Report & Capital Efficiency Focused Ideas - Newser
Published on: 2025-08-13 06:48:48 - Newser
Top chart patterns to watch in TriSalus Life Sciences Inc.2025 Institutional Moves & Daily Chart Pattern Signals - Newser
Will TriSalus Life Sciences Inc. price bounce be sustainableTrade Risk Assessment & Growth Oriented Trading Recommendations - Newser
Applying big data sentiment scoring on TriSalus Life Sciences Inc. Equity WarrantMarket Performance Report & Reliable Entry Point Alerts - Newser
Tick level data insight on TriSalus Life Sciences Inc. Equity Warrant volatility2025 Geopolitical Influence & Verified Momentum Stock Alerts - Newser
Using economic indicators to assess TriSalus Life Sciences Inc. Equity Warrant potential - Newser
Published on: 2025-08-13 02:06:42 - Newser
Using RSI to spot recovery in TriSalus Life Sciences Inc. Equity WarrantFree AI Based High Gain Watchlist Scanner - Newser
TriSalus Life Sciences Reports Strong Q2 2025 Growth - TipRanks
What makes TriSalus Life Sciences Inc. Equity Warrant stock price move sharplyInvestment Roadmap for High Potential Stocks - Newser
Candlestick signals on TriSalus Life Sciences Inc. stock todayLong Term Stock Growth Plan Suggestions - Newser
Will TriSalus Life Sciences Inc. see short term momentumBear Alert & Momentum Based Trading Signals - Newser
TriSalus outlines 50% revenue growth target for 2025 while advancing TriNav platform and streamlining costs - MSN
How TriSalus Life Sciences Inc. stock performs during market volatility2-Day Signal Watch with Forecast Outcome - Newser
Earnings call transcript: TriSalus Life Sciences Q2 2025 sees strong revenue growth - Investing.com
TriSalus Life Sciences, Inc. (TLSI) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
TriSalus Life Sciences Q2 rev. up 52% YoY to $11.2mln. - AInvest
TriSalus Life Sciences Reports Second Quarter 2025 Results and Reiterates 2025 Guidance - Bluefield Daily Telegraph
Can TriSalus Life Sciences Inc. Equity Warrant rally from current levelsHigh Return Idea With Technical Filter - Newser
Analyzing recovery setups for TriSalus Life Sciences Inc. investorsSteady Return Plan Based on Data Analysis - Newser
Can trapped investors hope for a rebound in TriSalus Life Sciences Inc.Free Reliable Alerts for Daily Stock Movers - Newser
How TriSalus Life Sciences Inc. Equity Warrant stock performs during market volatilityWealth Accumulation Outlook for Safe Investors - Newser
Chart based analysis of TriSalus Life Sciences Inc. Equity Warrant trendsConservative Investment Setup and Risk Analysis - Newser
TriSalus Life Sciences Inc. Equity Warrant stock trend outlook and recovery pathTechnical Reversal Setup with Risk Limits - Newser
Chart based exit strategy for TriSalus Life Sciences Inc. Equity WarrantHigh Win Rate Strategy with Stop Protection - Newser
Is this a good reentry point in TriSalus Life Sciences Inc.Portfolio Review Summary with Five-Year Outlook - Newser
Detecting support and resistance levels for TriSalus Life Sciences Inc.Momentum Trading Guide with Safety Limits - Newser
TriSalus study shows promising results for thyroid disease treatment - Investing.com
Breakthrough Thyroid Procedure Achieves 73% Size Reduction: New Clinical Data Reveals Game-Changing Results - Stock Titan
Is TriSalus Life Sciences Inc. Equity Warrant stock entering bullish territoryDaily Upside Movement Prediction With Data - Newser
Why TriSalus Life Sciences Inc. stock attracts strong analyst attentionTrading Watchlist with Real Time Filters - Newser
Published on: 2025-08-11 02:05:07 - Newser
Published on: 2025-08-10 22:56:45 - Newser
Has TriSalus Life Sciences Inc. Equity Warrant formed a bullish divergencePortfolio Allocation Strategy for Stability - Newser
Is TriSalus Life Sciences Inc. Equity Warrant Stock a Good Fit for Conservative InvestorsRisk-Managed Strategy Based on Price Analysis - Newser
Order flow analysis tools used on TriSalus Life Sciences Inc. Equity WarrantFree Long Hold Safe Return Strategy - Newser
News impact scoring models applied to TriSalus Life Sciences Inc.ROI Prediction from Long-Term Holding Plans - Newser
Applying sector rotation models to TriSalus Life Sciences Inc. Equity WarrantFree High Yield Stocks With Buy Confirmation - Newser
Can TriSalus Life Sciences Inc. Rally Enough to Break EvenExpert Verified Stock Trade Ideas Backed by Data - beatles.ru
Is TriSalus Life Sciences Inc. trending in predictive chart modelsBuy and Hold Strategy for Capital Safety - Newser
Earnings Preview: TLSI to Report Financial Results Post-market on August 12 - 富途牛牛
TriSalus Life Sciences Inc. Equity Warrant stock outlook for YEARAccurate Forecast System with AI Support - Newser
Finanzdaten der Trisalus Life Sciences Inc-Aktie (TLSI)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.31%
1.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):